Use of NASBA® RNA Amplification for Detection of Mycobacterium leprae in Skin Biopsies from Untreated and Treated Leprosy Patients

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 4, 1996, Pages 396-403

  Van Der Vliet, Gabrielle M E ^a   Cho, Sang Nae ^b   Kampirapap, Kowit ^c   Van Leeuwen, Jannet ^a   Schukkink, Rianne A F ^d   Van Gemen, Bob ^d   Das, Pran K ^e   Faber, William R ^e   Walsh, Gerald P ^f   Klatser, Paul R ^a  

^a ROYAL TROPICAL INSTITUTE   (Netherlands)

^b Yonsei University College of Medicine   (South Korea)

^c Soi Bamrasnaradoon Hospital   (Thailand)

^d Organon Teknika   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f Leonard Wood Memorial Center for Leprosy Research Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; GENE AMPLIFICATION; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; SKIN BIOPSY; TREATMENT OUTCOME; BACTERIAL COUNT; BIOPSY; COMPARATIVE STUDY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; NUCLEIC ACID AMPLIFICATION; SKIN;

BACTERIAL RNA; RNA 16S;

BIOPSY; COLONY COUNT, MICROBIAL; HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; SKIN;

EID: 0030466583     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BOOM, R., SOL, C. J. A., SALIMANS, M. M. M., JANSEN, C. L., WERTHEIM-VAN DILLEN, P. M. E. and VAN DER NOORDAA, J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28 (1990) 459-503.
2. CHANG, Y. T. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals? Int. J. Lepr. 45 (1976) 235-240.
3. COLSTON, M. J., ELLARD, G. A., FERRACCI, C. A. P., GROSSET, J. H., GROSSETETE, G., IYER, C. G. S., JACOBSON, R. R., JI, B., LWIN, K., LEIKER, D. L., LEVY, L, NOORDEEN, S. K. and PATTYN, S. R. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chigleput. Lepr. Rev. 58 (1987) 325-337.
4. COLSTON, M. J., HILSON, G. R. F. and BANERJEE, D. K. The "proportional bactericidal test": a method for assessing bactericidal activity of drugs against Mycobacterium leprae in mice. Lepr. Rev. 49 (1978) 7-15.
5. COMPTON, J. Nucleic acid sequence-based amplification. Nature 350 (1991) 91-92.
6. DE WIT, M. Y. L., FABER, W. R., KRIEG, S. R., DOUGLAS, J. T., LUCAS, S. B., MONTREEWASUWAT, N., PATTYN, S. R., HUSSAIN, R., PONNIGHAUS, J. M., HARTSKEERL, R. A. and KLATSER, P. R. Application of a polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues. J. Clin. Microbiol. 29 (1991) 906-910
7. DHOPLE, A. M. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients. Int. J. Lepr. 52 (1983) 183-188.
8. GROSSET, J.-H. Progress in the chemotherapy of leprosy. Int. J. Lepr. 62 (1994) 268-277.
9. JAMIL, S., KEER, J. T., LUCAS, S. B., DOCKRELL, H. M., CHIANG, T. J., HUSSAIN, R. and STOKER, N. G. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy. Lancet 342 (1993) 264-268.
10. KATOCH, V. M., KATOCH, K., RAMANATHAN, U., SHARMA, V. D., SHIVANNAVAR, C. T., DATTA, A. K. and BHARADWAJ, V. P. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining. Int. J. Lepr. 57 (1988) 615-621.
11. KAWA, D. E., PENNELL, D. R., KUBISTA, L. N. and SCHELL, R. F. Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the gen-probe DNA hybridization system. Antimicrob. Agents Chemother. 33 (1989) 1000-1005.
12. KLATSER, P. R. Serology of leprosy. Trop. Geogr. Med. 46 (1994) 115-118.
13. KVACH, J. T. and J. R. VERAS. A fluorescent staining procedure for determining the viability of mycobacterial cells. Int. J. Lepr. 50 (1982) 183-192.
14. RIDLEY, R. S. Pathogenesis of Leprosy and Related Diseases, London: John Wright, 1988, p. 240.
15. SEYDEL, U., HAAS, M., RIETSCHEL, E. T. and LINDNER, B. Laser microprobe mass spectrometry of individual bacterial organisms and of isolated bacterial compounds: a tool in microbiology. J. Microbiol. Meth. 15 (1992) 167-183.
16. SHEPARD, C. C. A kinetic method for the study of activity of drugs against Mycobacterium leprae in mice. Int. J. Lepr. 35 (1967) 429-454.
17. SILVA, M. T., APPELBERG, R., SILVA, N. T. and MACEDO, P. M. In vivo killing and degradation of Mycobacterium aurum within mouse peritoneal macrophages. Infect. Immun. 55 (1987) 2006-2016.
18. VAN DER VLIET, G. M. E., SCHEPERS, P., SCHUKKINK, R. A. F., VAN GEMEN, B. and KLATSER, P. R. Assessment of mycobacterial viability through RNA-amplification. Antimicrob. Agents Chemother. 38 (1994) 1959-1965.
19. VAN DER VLIET, G. M. E., SCHUKKINK, R. A. F., VAN GEMEN, B., SCHEPER, P. and KLATSER, P. R. Nucleic acid sequence-based amplification (NASBA) for the identification of mycobacteria. J. Gen. Microbiol. 139 (1993) 2423-2429.
20. VAN GEMEN, B., VAN BEUNINGEN, R., NABBE, A., VAN STRIJP, D., JURRIAANS, S., LENS, P. and KIEVITS, T. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J. Virol. Methods 49 (1994) 157-168.
21. WATERS, M. F. R. and REES, R. J. W. Changes in the morphology of Mycobacterium leprae in patients under treatment. Int. J. Lepr. 30 (1962) 266-277.
22. WELCH, T. M., GELBER, R. H., MURRAY, L. P., O'NEILL, S. M. and LEVY, L. Viability of Mycobacterium leprae after multiplication in mice. Infect. Immun. 30 (1980) 325-328.
23. WICHITWECHKARN, J., KARNJAN, S., SHUNTAWUTTISETTEE, S., SORNPRASIT, C., KAMPIRAPAP, K. and PEERAPAKORN, S. Detection of Mycobacterium leprae infection by PCR. J. Clin. Microbiol. 33 (1995) 45-49.
24. WILLIAMS, D. L., GILLIS, T. P., FIALLO, P., JOB, C. K., GELBER, R. H., HILL, C. and IZUMI, S. Detection of Mycobacterium leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol. Cell Probes 6 (1992) 401-410.
25. WHO COMMITTEE ON EXPERIMENTAL CHEMOTHERAPY. Experimental chemotherapy in leprosy. Bull. WHO 53 (1976) 425-433.
26. WORLD HEALTH ORGANIZATION. Eliminating leprosy as a public health problem before the year 2000. Geneva: World Health Organization, 1994.
27. YOON, K.-H., CHO, S.-N., LEE, M.-K., ABALOS, R. M., CELLONA, R. V., FAJARDO, T. T., JR., GUIDO, L. S., DELA CRUZ, E. C., WALSH, G. P. and KIM, J.-D. Evaluation of the polymerase chain reaction amplification of Mycobacterium leprae-specific repetitive sequence in biopsy specimens from leprosy patients. J. Clin. Microbiol. 31 (1993) 895-899.